Mylan CEO defends EpiPen price hike in congressional hearing

The fight over the price of the EpiPen, an emergency treatment device for severe allergic reactions, has officially reached Capitol Hill. CEO Heather Bresch of Mylan, the company that makes the EpiPen, defended the drug's drastic price increase during a congressional hearing Wednesday as a balance between "price and access," pointing out that Mylan only profits $50 for each two-pack sold and that it has in the past distributed EpiPens to schools for free.
"Looking back, I wish we had better anticipated the magnitude and acceleration of the rising financial issues for a growing minority of patients, who may have ended up paying the [list price] or more. We never intended this," Bresch said in a statement released ahead of the hearing.
Rep. Elijah Cummings (D-Md.) accused Mylan of raising the price of a potentially lifesaving drug — despite keeping its ingredients virtually unchanged — when it acquired EpiPen in 2007, in order "to get filthy rich at the expense of our constituents." Cummings also compared Mylan's tactics to those of Martin Shkreli, the widely-loathed pharmaceutical executive who raised the price of a lifesaving cancer and HIV drug by 5,000 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since Mylan acquired EpiPen, the price of the device has risen more than 500 percent, to $608 for a two-pack.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages